Recyclable ophthalmic instrument company HASA OPTIX receives B Corporation certification

News
Article

The Belgian B Corp company, founded in 2016, is partially owned by Rayner and distributed in over 20 European countries

The B Corp certification symbol on a phone, and the B Lab website on a computer. Image credit: ©Timon – stock.adobe.com

Currently, HASA OPTIX products are available in markets throughout Europe, the US, the Middle East and Australia. Image credit: ©Timon – stock.adobe.com

Recyclable ophthalmic instrument company HASA OPTIX announced its certification as a B Corporation (B Corp) company by nonprofit B Lab. In a press release, the Brussels, Belgium-based HASA OPTIX confirmed it has achieved a score of 109.7 points on the B Impact Assessment. Companies must score between 80 and 200 points to earn the B Corp label. The nonprofit assesses key impact areas including governance, workers, community, environment and customers.

HASA OPTIX, partially owned by Rayner, designs and distributes recyclable single-use ophthalmic surgery instruments. In a press release, HASA OPTIX described its innovative instrument recycling framework, which sees the company “recycling the stainless steel the instruments are made of, and reusing them to make other, non-medical, products.” The company received the B Corp certification by displaying responsible practices in energy use, water use, waste creation and disposal, worker compensation, diversity and corporate transparency.

Currently, HASA OPTIX products are available in select markets, including several countries in Europe: Austria, Belgium, Czechia, Denmark, Finland, France, Germany, Greece, Ireland, Latvia, the Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, Switzerland and the UK. The company also has distribution partnerships throughout the US, the Middle East and Australia.

Eric T’Scharner, CEO of HASA OPTIX, said in a press release that the B Corp label will further help the company’s clinician end users align their environmental goals and commitment to sustainable practices.

“We even see an impact on staff who may feel more engaged and motivated to work for an institution that prioritises [environmental, social, and governance principles,]” he stated. “We remark that hospitals that work with HASA OPTIX can position themselves as leaders in ethical sourcing and sustainability within the healthcare industry, setting benchmarks for others to follow.”

Earlier this year, HASA OPTIX was shortlisted as one of Belgium’s Most Sustainable Companies by the local Trends Impact Awards. As of Q4 2024, B Lab has certified over 8,900 B Corps in 92 countries.

Reference
  1. HASA OPTIX Certifies as a B Corporation. News release. HASA OPTIX and Rayner. Published 25 October, 2024. Accessed 2 December, 2024.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
© 2025 MJH Life Sciences

All rights reserved.
OSZAR »